Physician

Atul Sadashiv Rao, M.D.

According to 2025 Medicare claims, Atul Rao, M.D. (NPI: 1366607541) practices vascular surgery in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Bucks, PA. This provider's primary affiliated billing organization is VIA AFFILIATES (NPI: 1003446261; TIN: 232368197) and primary practice location at 18901-2554. Rao is affiliated with the Delaware Valley ACO (ACO ID: A2024), Capital Health Accountable Care Organization, LLC (ACO ID: A2528), and Doylestown Value Partners, LLC (ACO ID: A5245), participating under the MSSP model.

Rao's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 943 traditional Medicare patients, billed 1,833 HCPCS/CPT codes, and received $184,384 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 140 prescription claims across 58 beneficiaries totaling $45,827 in drug costs, led by Xarelto (Rivaroxaban). 2020 DME data shows 63 claims. Open Payments data shows 16 records totaling $945. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $14,238 to $45,827. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	374	965	$126,606
2016	252	685	$120,113
2017	323	987	$172,975
2018	405	1,119	$178,591
2019	513	1,370	$221,904
2020	460	1,148	$175,316
2021	462	990	$169,484
2022	754	1,583	$174,483
2023	899	1,855	$200,486
2024	943	1,833	$184,384

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	31	74	$14,238
2016	26	64	$14,039
2017	33	70	$3,814
2018	49	116	$7,812
2019	54	141	$13,753
2020	60	141	$28,390
2021	47	138	$33,066
2022	56	169	$40,230
2023	60	180	$49,942
2024	58	140	$45,827

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	35	$9,322
2018	N/R	22	$2,496
2019	N/R	N/R	N/R
2020	N/R	63	$14,489
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	124	154	$101
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	251	274	$68
93925	Ultrasound of leg arteries or artery grafts	175	178	$28
93880	Ultrasound of both sides of head and neck blood flow	239	241	$27
93922	Ultrasound study of arm and leg arteries	178	181	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	26	1,740	$31,090
Clopidogrel	Clopidogrel Bisulfate	69	5,490	$1,293
Cilostazol	Cilostazol	18	1,500	$1,000
Methylprednisolone	Methylprednisolone	14	14	$76

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$945	Endologix LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Atul Sadashiv Rao, M.D.?

Tedicare shows public-source Medicare data for Atul Sadashiv Rao, M.D. (NPI 1366607541), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Atul Sadashiv Rao, M.D. have ACO affiliation data?

Atul Sadashiv Rao, M.D. is shown with ACO affiliation data for Delaware Valley ACO (MSSP, ACO ID A2024), Capital Health Accountable Care Organization, LLC (MSSP, ACO ID A2528), and Doylestown Value Partners, LLC (MSSP, ACO ID A5245).

What billing organization is linked to Atul Sadashiv Rao, M.D.?

Atul Sadashiv Rao, M.D. is linked to VIA AFFILIATES (billing NPI 1003446261) in the available physician profile data.

Does Atul Sadashiv Rao, M.D. have Open Payments data?

Atul Sadashiv Rao, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.